Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

Clinical trial NCT05098704 · RECRUITING

Trial details

NCT number: NCT05098704
Sponsor: University Hospital, Bordeaux
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Scleroderma Systemic Sclerosis

Start date: 2022-06-22
Primary completion: 2032-06-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.